This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson’s Disease
Published September 10, 2024
Output Details
Published September 10, 2024
Description
Glucocerebrosidase (*GBA1*) variants constitute numerically the most common known genetic risk factor for Parkinson's disease (PD) and are distributed worldwide. Access to *GBA1* genotyping varies across the world and even regionally within countries. Guidelines for *GBA1* variant counseling are evolving. We review the current knowledge of the link between *GBA1* and PD, and discuss the practicalities of *GBA1* testing. Lastly, we provide a consensus for an approach to counseling people with *GBA1* variants, notably the communication of PD risk. © 2024 The Author(s). *Movement Disorders* published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Identifier (DOI)
10.1002/mds.30006